One page, thousands of outlets. See who else covered it.
It’s not the purchase price that’s the biggest obstacle, but rather the continuing costs.
We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.
Moderna stock surged after its mRNA cancer vaccine showed positive Phase 3 results with Merck’s Keytruda, boosting hopes for a new melanoma treatment.
The US 10-year Treasury yield declines sharply on Wednesday, trading at 4.651% at the time of writing after reaching an intraday high of 4.712%.
Chilean lithium producer SQM earned US$660.0 million in the second quarter of 2026, up 646.4% on the year, as prices recovered and sales volumes hit a record.
